AMP 2020

The Illumina mission is to improve human health by unlocking the power of the genome. Now, through innovation and collaboration, we are enabling genomic breakthroughs in immunotherapy, biomarker discovery, and therapy selection. The opportunity to transform tumor profiling with innovative assays that enable comprehensive genomic profiling, new companion diagnostic development, and liquid biopsy inspires us to push boundaries and drive innovation.

Visit us at our virtual booth to learn more about our solutions and attend our featured corporate workshop talks.

Join us on Twitter on Monday, November 16, 9:00 am PST, for a live Q&A event to learn more about a simpler, faster and more scalable CGP workflow from Illumina’s own product team. Follow @IlluminaLive on Twitter to receive updates around our AMP events.

The following workshops will be available on-demand as of November 10, 2020.

1. Workshop: Flexible Capabilities to Enable Comprehensive Genomic Profiling

Speakers:

Nikoletta Sidiropoulos, MD
Associate Professor & Director Molecular Pathology,
University of Vermont, Larner College of Medicine

Jeffrey Conroy 
Chief Scientific Officerand Director Genomics Technologies,
OmniSeq Inc., Roswell Park Comprehensive Cancer Center

Jeremy Wallentine, MD 
Pathologist,
Intermountain Health

2.  Workshop: Comprehensive Genomic Profiling (CGP) from liquid biopsy samples in clinical trials

Speakers:

Chris Karlovich, PhD
Associate Director of the Molecular Characterization Lab (MoCha), Frederick National Laboratory for Cancer Research

3.  Workshop: Sequencing-based spatial analyses

Speakers:

Jonathan Chen, MD PhD
Instructor in Pathology,
Department of Pathology,
Massachusetts General Hospital

Jaclyn Hechtman, MD
Associate Attending Pathologist, 
Memorial Sloan Kettering Cancer Center

Jodi M. Carter, MD PhD
Assistant Professor of Laboratory Medicine and Pathology,
Department of Laboratory Medicine and Pathology,
Mayo Clinic

4.   Workshop: Next-generation sequencing (NGS) applications for SARS-CoV-2 detection and surveillance

Speaker:

Kelly Hoon
Infectious Disease Specialist,
Illumina

Click to learn more about Illumina’s solutions.

	Trusight Oncology 500 Portfolio Updates: Improvements to enable a simpler, faster, and more scalable sample-to-answer workflow for in-house comprehensive genomic profiling (CGP).
	NovaSeq™ 6000 Sequencing System
	NextSeq™ 550 DX Sequencing system
	Covid-19 Solutions
	DRAGEN™ Bio-IT Platform